Evidence map›Paper›PMID 42786174›Full record

ArticleNature communications2026

Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue.

Aram Aslanyan, Soumya Mukherjee, Eleanor M Moncur, Alicja Szadziewska, Yingxin He, Przemysław R Kac, Reid Coyle, Elena Camporesi, Chihiro Sato, Nupur Ghoshal and 23 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Aram Aslanyan *Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK. a.aslanyan@ucl.ac.uk.ORCID 0000-0003-3220-6313
Soumya Mukherjee *Department of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.ORCID 0000-0001-5326-4008
Eleanor M MoncurNational Hospital for Neurology and Neurosurgery, London, UK.
Alicja SzadziewskaDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0002-8377-9309
Yingxin HeDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.ORCID 0000-0003-2543-4553
Przemysław R KacDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0001-5083-0924
Reid CoyleDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.
Elena CamporesiDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0003-1044-0192
Chihiro SatoDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.ORCID 0000-0002-7639-8727
Nupur GhoshalDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.ORCID 0000-0002-6680-6731
Nicolas R BarthélemyDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.ORCID 0000-0003-4937-2860
Jack WoodDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0001-6049-4020
Junyue GeDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0009-0005-9542-802X
Maciej DulewiczDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0002-7149-017X
Srinivas KoutarapuDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.
Katherine SchwetyeDepartment of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Kaleigh F RobertsDepartment of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.ORCID 0000-0001-6483-9153
Eimear C MurphyDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Francesco CarlettiNational Hospital for Neurology and Neurosurgery, London, UK.ORCID 0000-0002-6756-6442
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Fernando Gonzalez OrtizDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0001-7897-9456
Claire A LeckeyDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Tatiana A GiovannucciDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0001-8978-6318
Kanza TariqNational Hospital for Neurology and Neurosurgery, London, UK.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.ORCID 0000-0003-3930-4354
Donald L ElbertDepartment of Neurology, University of Washington, Seattle, WA, USA.ORCID 0000-0001-6480-9536
Lewis ThorneNational Hospital for Neurology and Neurosurgery, London, UK.ORCID 0000-0002-7692-0378
Ahmed K TomaNational Hospital for Neurology and Neurosurgery, London, UK.
Laurence WatkinsNational Hospital for Neurology and Neurosurgery, London, UK.ORCID 0000-0003-0678-3774
Nick C FoxDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0002-6660-657X
Randall J BatemanDepartment of Neurology, Washington University School of Medicine in St Louis, St Louis, MO, USA.ORCID 0000-0002-7729-1702
Jörg HanriederDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Ross W PatersonDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK. r.paterson@ucl.ac.uk.ORCID 0000-0001-9372-3635

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
Understanding Amyloid Pathology - Multiomic Activity Imaging of Plaque Formation Dynamics (AmyMAP)R01AG078796 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Jeffrey Nicholas Savas · 2022 to 2026
$2.7M
Tau Kinetics in the human CNS in vivo and in vitroK01AG062796 · NIA · WASHINGTON UNIVERSITY · PI SATO, CHIHIRO · 2019 to 2022
$477k
Human in vivo stable isotope labeling kinetics (iSILK) to quantify brain amyloid plaque kineticsR21AG078538 · NIA · WASHINGTON UNIVERSITY · PI HANRIEDER, JORG, SCHWETYE, KATHERINE · 2022 to 2022
$411k
Insights into Amyloid Pathogenicity DynamicsR21AG080705 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HANRIEDER, JORG, SAVAS, JEFFREY NICHOLAS · 2023 to 2024
$401k
BCL-XL AND BCL-XS PROTEINS AND APOPTOSISF32AG005691 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SIMONIAN, PHILIP LEVON · 1994 to 1996
–
Alzheimer's Association PTC-22-982162NIA NIH HHS F32 AG005691NIA NIH HHS K01 AG062796NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS R01 AG078796NIA NIH HHS R21 AG078538NIA NIH HHS R21 AG080705NIGMS NIH HHS P41 GM103422
6 · The paper itself

Abstract

Alzheimer disease begins in the brain many years before symptoms, but early changes are usually studied after death or indirectly through fluid and imaging biomarkers. Here we show that small brain biopsies collected during ventriculoperitoneal shunt surgery can be used to study Alzheimer disease pathology and protein turnover during life. We analysed biopsies from 18 individuals with suspected normal pressure hydrocephalus, alongside matched ventricular and lumbar cerebrospinal fluid and post-mortem control brain tissue. Amyloid plaques were present in 9 of 18 biopsies, while mature tau tangles were rare. Matrix-assisted laser desorption/ionization mass spectrometry imaging mapped amyloid plaque chemistry within tissue. Phosphorylated tau 217 was enriched around plaques, supporting a local relationship between amyloid and tau pathology. Stable isotope labelling, which tracks newly made proteins, detected rapid tau labelling within approximately 3 hours and estimated brain tau half-life at about 34 days. Amyloid plaques showed little detectable turnover.

Indexed as

Alzheimer DiseaseBrainAgedAged, 80 and overBiopsyFemaleHumansHydrocephalus, Normal PressureMalePhosphorylationPlaque, AmyloidSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionizationtau Proteinstau Proteins

Identifiers

PMID42786174
PMCPMC13612511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.